{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-Alzheimer's", "anti-radical", "benzimidazole-2-thiol", "heterocycles", "molecular docking"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32897587", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "08"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "09", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1002/ddr.21740"], "Journal": {"ISSN": "1098-2299", "JournalIssue": {"Volume": "82", "Issue": "2", "PubDate": {"Year": "2021", "Month": "Apr"}}, "Title": "Drug development research", "ISOAbbreviation": "Drug Dev Res"}, "ArticleTitle": "New multitarget directed benzimidazole-2-thiol-based heterocycles as prospective anti-radical and anti-Alzheimer's agents.", "Pagination": {"StartPage": "207", "EndPage": "216", "MedlinePgn": "207-216"}, "Abstract": {"AbstractText": ["A series of new heterocycles (4-18) was synthesized by the structural modification of benzimidazole-2-thiol (BT, 2-MBI). The structures of the synthesized compounds were confirmed with the help of high-resolution mass spectrometry (HRMS) and <sup>1</sup> HNMR spectroscopy. High inhibitions of the oxidants such as ABTS and DPPH were observed for compounds 9 [IC<sub>50</sub> (s) = 167.4 \u03bcM (ABTS), 139.5 \u03bcM (DPPH)], 10 [IC<sub>50</sub> (s) = 186.5 \u03bcM (ABTS), 155.4 \u03bcM (DPPH)], 11 [IC<sub>50</sub> (s) = 286.1 \u03bcM (ABTS), 189.1 \u03bcM (DPPH)], 12 [IC<sub>50</sub> (s) = 310.8 \u03bcM (ABTS), 162.2 \u03bcM (DPPH)], 14 [IC<sub>50</sub> (s) = 281.3 \u03bcM (ABTS), 205.7 \u03bcM (DPPH)], 15 [IC<sub>50</sub> (s) = 284.1 \u03bcM (ABTS), 177.3 \u03bcM (DPPH)], and 16 [IC<sub>50</sub> (s) = 344.7 \u03bcM (ABTS), 270.2 \u03bcM (DPPH)] as compared with Ascorbic acid [IC<sub>50</sub> (s) = 340.9 \u03bcM (ABTS), 164.3 \u03bcM (DPPH)]. The anti-Alzheimer's activity was performed in vitro against cholinesterase enzymes (AChE, BChE). Compound 11 was able to show significant inhibitions [IC<sub>50</sub> (s) = 121.2 \u03bcM (AChE), 38.3 \u03bcM (BChE)] as against that of galantamine [IC<sub>50</sub> (s) = 139.4 \u03bcM (AChE), 40.3 \u03bcM (BChE)]. Compound 14 was found as a very good inhibitor of butyrylcholinesterase (IC<sub>50</sub> = 35.4 \u03bcM) as compared with standard galantamine. Molecular docking was further performed to investigate the mechanism of anticholinesterase activity."], "CopyrightInformation": "\u00a9 2020 Wiley Periodicals, LLC."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Malakand, Chakdara, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Latif", "ForeName": "Abdul", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Malakand, Chakdara, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Bibi", "ForeName": "Samina", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Malakand, Chakdara, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Ali", "ForeName": "Sardar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Malakand, Chakdara, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Ammara", "ForeName": "Ammara", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Malakand, Chakdara, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Ahmad", "ForeName": "Manzoor", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "UoN Chair of Oman's Medicinal Plants and Marine Natural Products, University of Nizwa, Nizwa, Sultanate of Oman."}], "LastName": "Khan", "ForeName": "Ajmal", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "UoN Chair of Oman's Medicinal Plants and Marine Natural Products, University of Nizwa, Nizwa, Sultanate of Oman."}], "LastName": "Al-Harrasi", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Ullah", "ForeName": "Farhat", "Initials": "F"}, {"Identifier": ["0000-0002-3329-4039"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Malakand, Chakdara, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Ali", "ForeName": "Mumtaz", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Drug Dev Res", "NlmUniqueID": "8204468", "ISSNLinking": "0272-4391"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Benzimidazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Free Radical Scavengers"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfhydryl Compounds"}, {"RegistryNumber": "E24GX49LD8", "NameOfSubstance": "benzimidazole"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["administration & dosage", "chemical synthesis"], "DescriptorName": "Benzimidazoles"}, {"QualifierName": ["methods"], "DescriptorName": "Chemistry, Pharmaceutical"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": ["administration & dosage", "chemical synthesis"], "DescriptorName": "Free Radical Scavengers"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["methods"], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Protein Structure, Secondary"}, {"QualifierName": ["administration & dosage", "chemical synthesis"], "DescriptorName": "Sulfhydryl Compounds"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aboul-Enein, H., & El Rashedy, A. (2015). Benzimidazole derivatives as antidiabetic agents. Medicinal Chemistry, 5(7), 318-325. https://doi.org/10.4172/2161-0444.1000280"}, {"Citation": "Ali, M., Ali, S., Khan, M., Rashid, U., Ahmad, M., Khan, A., . . . Latif, A. (2018). Synthesis, biological activities, and molecular docking studies of 2-mercaptobenzimidazole based derivatives. Bioorganic Chemistry, 80, 472-479. https://doi.org/10.1016/j.bioorg.2018.06.032"}, {"Citation": "Alkhafaji, A., Muhi-Eldeen, Z., Al-Kaissi, E., Al-Muhtaseb, N., Arafat, T., & Ghattas, M. A. (2018). Synthesis, structural elucidation, and evaluation of antimicrobial activity of 5-ethoxy-2-mercaptobenzimidazole derivatives. International Journal of Medical Research & Health Sciences, 7(5), 117-127."}, {"Citation": "Amer, H. H., Ali, O. M., & El-Kafaween, I. K. (2017). Synthesis of some new nucleosides derived from 2-mercapto benzimidazole with expected biological activity. Oriental Journal of Chemistry, 33(5), 2303-2310. https://doi.org/10.13005/ojc/330519"}, {"Citation": "Anandarajagopal, K., Tiwari, R. N., Bothara, K., Sunilson, J. A. J., Dineshkumar, C., & Promwichit, P. (2010). 2-Mercaptobenzimidazole derivatives: Synthesis and anticonvulsant activity. Advances in Applied Science Research, 1(2), 132-138."}, {"Citation": "Annamala, M. K., Inampudi, K. K., & Guruprasad, L. (2007). Docking of phosphonate and trehalose analog inhibitors into M. tuberculosis mycolyltransferase Ag85C: Comparison of the two scoring fitness functions GoldScore and ChemScore, in the GOLD software. Bioinformation, 1(9), 339-350. https://doi.org/10.6026/97320630001339"}, {"Citation": "Chauhan, D., Hati, S., Priyadarshini, R., & Sen, S. (2019). Transcriptome analysis predicts mode of action of benzimidazole molecules against Staphylococcus aureus UAMS-1. Drug Development Research, 80(4), 490-503. https://doi.org/10.1002/ddr.21523"}, {"Citation": "Keri, R. S., Hiremathad, A., Budagumpi, S., & Nagaraja, B. M. (2015). Comprehensive review in current developments of benzimidazole-based medicinal chemistry. Chemical Biology & Drug Design, 86(1), 19-65. https://doi.org/10.1111/cbdd.12462"}, {"Citation": "Nevade, S. A., Lokapure, S. G., & Kalyane, N. V. (2013). Synthesis and pharmacological evaluation of some novel 2-mercapto benzimidazole derivatives. Journal of the Korean Chemical Society, 57(6), 755-760. https://doi.org/10.5012/jkcs.2013.57.6.755"}, {"Citation": "Politi, A., Durdagi, S., Moutevelis-Minakakis, P., Kokotos, G., & Mavromoustakos, T. (2010). Development of accurate binding affinity predictions of novel renin inhibitors through molecular docking studies. Journal of Molecular Graphics and Modelling, 29(3), 425-435. https://doi.org/10.1016/j.jmgm.2010.08.003"}, {"Citation": "Rasool, S. R., & Saadon, A. (2014). Barbituric acid as a core for some new heterocyclic substituted derivatives. Journal of Applicable Chemistry, 3(1), 74-81."}, {"Citation": "Sen, J., & Srivastava, S. (2009). Synthesis and antimicrobial activity of some new 2-[2\u2033, 3\u2033-dinitrophenyl]-3-(substituted aryl)-3, 3a-dihydrobenzimidazo [2, 1-a] pyrazolo [3, 4-d] thiazoles derivatives. International Journal of Theoretical & Applied Sciences, 1(1), 41-47."}, {"Citation": "Syunyakov, T., & Neznamov, G. (2016). Evaluation of the therapeutic efficacy and safety of the selective anxiolytic afobazole in generalized anxiety disorder and adjustment disorders: Results of a multicenter randomized comparative study of diazepam. Terapevticheskii Arkhiv, 88(8), 73-86. https://doi.org/10.17116/terarkh201688873-86"}, {"Citation": "Tahlan, S., Kumar, S., & Narasimhan, B. (2019a). Antimicrobial potential of 1H-benzo [d] imidazole scaffold: a review. BMC Chemistry, 13(1), 18. https://doi.org/10.1186/s13065-019-0521-y"}, {"Citation": "Tahlan, S., Kumar, S., Ramasamy, K., Lim, S. M., Shah, S. A. A., Mani, V., & Narasimhan, B. (2019b). In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents. BMC Chemistry, 13(1), 90. https://doi.org/10.1186/s13065-019-0608-5"}, {"Citation": "Tahlan, S., Kumar, S., Ramasamy, K., Lim, S. M., Shah, S. A. A., Mani, V., \u2026 Narasimhan, B. (2019c). Design, synthesis and biological profile of heterocyclic benzimidazole analogues as prospective antimicrobial and antiproliferative agents. BMC Chemistry, 13(1), 50. https://doi.org/10.1186/s13065-019-0567"}, {"Citation": "Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003). Improved protein-ligand docking using GOLD. Proteins: Structure, Function, and Bioinformatics, 52(4), 609-623. https://doi.org/10.1002/prot.10465"}, {"Citation": "Yadav, S., Narasimhan, B., Lim, S. M., Ramasamy, K., Vasudevan, M., Shah, S. A. A., & Selvaraj, M. (2017). Synthesis, characterization, biological evaluation and molecular docking studies of 2-(1H-benzo [d] imidazol-2-ylthio)-N-(substituted 4-oxothiazolidin-3-yl) acetamides. Chemistry Central Journal, 11(1), 137. https://doi.org/10.1186/s13065-017-0361-6"}, {"Citation": "Yerdelen, K. O., & Gul, H. I. (2013). Synthesis and anticholinesterase activity of fumaramide derivatives. Medicinal Chemistry Research, 22(10), 4920-4929. https://doi.org/10.1007/s00044-013-0493-8"}], "Title": "REFERENCES"}], "History": [{"Year": "2020", "Month": "8", "Day": "14"}, {"Year": "2020", "Month": "3", "Day": "24"}, {"Year": "2020", "Month": "8", "Day": "27"}, {"Year": "2020", "Month": "9", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "8", "Hour": "12", "Minute": "17"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32897587", "10.1002/ddr.21740"]}}]}